GPRE vs NBIX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPRE is a Hold and NBIX is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GPRE’s FA Score shows that 1 FA rating(s) are green whileNBIX’s FA Score has 0 green FA rating(s).
- GPRE’s FA Score: 1 green, 4 red.
- NBIX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GPRE’s TA Score shows that 5 TA indicator(s) are bullish while NBIX’s TA Score has 5 bullish TA indicator(s).
- GPRE’s TA Score: 5 bullish, 3 bearish.
- NBIX’s TA Score: 5 bullish, 3 bearish.
Price Growth
GPRE (@Chemicals: Specialty) experienced а +5.29% price change this week, while NBIX (@Pharmaceuticals: Other) price change was +5.28% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +2.12%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -10.52%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +5.53%. For the same industry, the average monthly price growth was -0.55%, and the average quarterly price growth was -7.74%.
Reported Earning Dates
GPRE is expected to report earnings on Jul 30, 2025.
NBIX is expected to report earnings on Aug 05, 2025.
Industries' Descriptions
@Chemicals: Specialty (+2.12% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
@Pharmaceuticals: Other (+5.53% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| GPRE | NBIX | GPRE / NBIX | |
| Capitalization | 1.47B | 13.7B | 11% |
| EBITDA | 53.6M | 358M | 15% |
| Gain YTD | -62.236 | -21.810 | 285% |
| P/E Ratio | N/A | 57.20 | - |
| Revenue | 3.3B | 1.89B | 175% |
| Total Cash | 350M | 1.03B | 34% |
| Total Debt | 677M | 428M | 158% |
GPRE | NBIX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 57 | 29 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | 71 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 70 | |
SMR RATING 1..100 | 91 | 57 | |
PRICE GROWTH RATING 1..100 | 97 | 79 | |
P/E GROWTH RATING 1..100 | 2 | 90 | |
SEASONALITY SCORE 1..100 | 75 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NBIX's Valuation (71) in the Biotechnology industry is in the same range as GPRE (94) in the Chemicals Specialty industry. This means that NBIX’s stock grew similarly to GPRE’s over the last 12 months.
NBIX's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as GPRE (100) in the Chemicals Specialty industry. This means that NBIX’s stock grew similarly to GPRE’s over the last 12 months.
NBIX's SMR Rating (57) in the Biotechnology industry is somewhat better than the same rating for GPRE (91) in the Chemicals Specialty industry. This means that NBIX’s stock grew somewhat faster than GPRE’s over the last 12 months.
NBIX's Price Growth Rating (79) in the Biotechnology industry is in the same range as GPRE (97) in the Chemicals Specialty industry. This means that NBIX’s stock grew similarly to GPRE’s over the last 12 months.
GPRE's P/E Growth Rating (2) in the Chemicals Specialty industry is significantly better than the same rating for NBIX (90) in the Biotechnology industry. This means that GPRE’s stock grew significantly faster than NBIX’s over the last 12 months.
| GPRE | NBIX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | 2 days ago 81% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 65% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 73% |
| MACD ODDS (%) | 2 days ago 88% | 2 days ago 65% |
| TrendWeek ODDS (%) | 2 days ago 75% | 2 days ago 70% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 61% |
| Advances ODDS (%) | about 1 month ago 75% | 2 days ago 71% |
| Declines ODDS (%) | 6 days ago 81% | 19 days ago 61% |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 71% |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 73% |
GPRE and
Correlation & Price change
A.I.dvisor indicates that over the last year, GPRE has been loosely correlated with REX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if GPRE jumps, then REX could also see price increases.
| Ticker / NAME | Correlation To GPRE | 1D Price Change % | ||
|---|---|---|---|---|
| GPRE | 100% | N/A | ||
| REX - GPRE | 52% Loosely correlated | +0.27% | ||
| ALB - GPRE | 47% Loosely correlated | -0.76% | ||
| NGVT - GPRE | 43% Loosely correlated | +0.09% | ||
| HUN - GPRE | 42% Loosely correlated | -0.22% | ||
| OLN - GPRE | 42% Loosely correlated | -1.03% | ||
More | ||||
NBIX and
Correlation & Price change
A.I.dvisor tells us that NBIX and LFCR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBIX and LFCR's prices will move in lockstep.
| Ticker / NAME | Correlation To NBIX | 1D Price Change % | ||
|---|---|---|---|---|
| NBIX | 100% | +0.92% | ||
| LFCR - NBIX | 32% Poorly correlated | +3.40% | ||
| EOLS - NBIX | 31% Poorly correlated | +0.87% | ||
| ACET - NBIX | 25% Poorly correlated | -4.62% | ||
| HROW - NBIX | 24% Poorly correlated | +1.91% | ||
| COLL - NBIX | 24% Poorly correlated | +0.04% | ||
More | ||||